Alpha 2.0
Login Register
» Authors » D Cunningham

D Cunningham

Explore the profile of D Cunningham including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 516
Citations 11074
Followers 0
Related Specialties
Oncology
General Medicine
General Surgery
Top 10 Co-Authors
A R Norman
I Chau
T Hickish
A Norman
J Oates
M Soukop
E Van Cutsem
G Brown
P J Ross
A Wotherspoon
Published In
Ann Oncol
Br J Cancer
Eur J Cancer
J Clin Oncol
Lancet
Affiliations
Soon will be listed here.
Recent Articles
1.
Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of Ireland
Vasseghi M, Behan C, Connolly A, Cunningham D, Dempsey E, Flynn C, et al.
J Rare Dis (Berlin) . 2024 Aug; 3(1):24. PMID: 39165678
Background: Tuberous sclerosis complex (TSC) is a rare approximate 1:6000 birth incidence, a genetic disease with a wide variability of physical and neuropsychiatric symptoms. Patients require lifelong care from multiple...
2.
Maintenance durvalumab after first-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study
Fong C, Patel B, Peckitt C, Bourmpaki E, Satchwell L, Cromarty S, et al.
ESMO Open . 2024 Jul; 9(7):103622. PMID: 39002179
Background: PLAnning Treatment For Oesophago-gastric Cancer: a Randomised Maintenance Therapy Trial (PLATFORM) is an adaptive phase II study assessing the role of maintenance therapies in advanced oesophago-gastric (OG) adenocarcinoma. We...
3.
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE
Cartwright E, Slater S, Saffery C, Tran A, Turkes F, Smith G, et al.
ESMO Open . 2024 Mar; 9(4):102971. PMID: 38518549
Background: Most oesophagogastric adenocarcinomas (OGAs) and colorectal cancers (CRCs) are mismatch repair proficient (MMRp), responding poorly to immune checkpoint inhibition. We evaluated the safety and efficacy of domatinostat (histone deacetylase...
4.
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study
Ajani J, El Hajbi F, Cunningham D, Alsina M, Thuss-Patience P, Scagliotti G, et al.
ESMO Open . 2023 Dec; 9(1):102202. PMID: 38118368
Background: The phase III RATIONALE-302 study evaluated tislelizumab, an anti-programmed cell death protein 1 antibody, as second-line (2L) treatment for advanced/metastatic esophageal squamous cell carcinoma (ESCC). This prespecified exploratory analysis...
5.
CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial
Saunders M, Graham J, Cunningham D, Plummer R, Church D, Kerr R, et al.
ESMO Open . 2022 Nov; 7(6):100594. PMID: 36327756
Background: Patients with microsatellite stable (MSS) colorectal carcinoma (CRC) do not respond to immune checkpoint inhibitors. Preclinical models suggested synergistic anti-tumour activity combining CXD101 and anti-programmed cell death protein 1...
6.
Radiology of Castleman disease: the pivotal role of imaging in diagnosis, staging, and response assessment of this rare entity
Din F, Mellor F, Millard T, Pace E, Khan N, Attygalle A, et al.
Clin Radiol . 2022 Feb; 77(6):399-408. PMID: 35177229
Castleman Disease (CD) is a rare entity that typically presents as an enhancing nodal mass in the mediastinum or head and neck region on computed tomography (CT). It may manifest...
7.
Inguinal hernia repair: a systematic analysis of online patient information using the Modified Ensuring Quality Information for Patients tool
Chien S, Cunningham D, Khan K
Ann R Coll Surg Engl . 2021 Dec; 104(4):242-248. PMID: 34931532
Background: Online resources are a fundamental source of healthcare information due to the increasing popularity of the internet. Ensuring accuracy and reliability of websites is crucial to improving patient education...
8.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): a good practice guide, pictorial review, and new perspectives
Mehdi A, Bitar G, Sharma R, Iyengar S, El-Sharkawi D, Tasoulis M, et al.
Clin Radiol . 2021 Sep; 77(2):79-87. PMID: 34579859
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare but emerging T-cell non-Hodgkin lymphoma. It has two distinct subtypes, "effusion-only" or "mass-forming" disease, arising around implants in patients with...
9.
Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigms
Musanhu E, Sharma R, Attygalle A, Wotherspoon A, Chau I, Cunningham D, et al.
Clin Radiol . 2021 Jul; 76(11):789-800. PMID: 34217434
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in adults. It is a malignancy of CD5 B-cells characterised by small, mature-appearing lymphocytes accumulating in the blood, bone marrow, and...
10.
Explosive Outbursts at School
Bostic J, Mattison R, Cunningham D
Child Adolesc Psychiatr Clin N Am . 2021 May; 30(3):491-503. PMID: 34053682
Explosive outbursts (EO) by students are an intensely distressing experience for that student as well as for all school staff and students present during the outburst. These EO are characterized...